nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropivacaine—CYP2B6—Sorafenib—liver cancer	0.132	0.289	CbGbCtD
Ropivacaine—CYP2B6—Doxorubicin—liver cancer	0.0802	0.175	CbGbCtD
Ropivacaine—CYP1A2—Sorafenib—liver cancer	0.0775	0.169	CbGbCtD
Ropivacaine—CYP2D6—Sorafenib—liver cancer	0.0639	0.139	CbGbCtD
Ropivacaine—CYP3A4—Sorafenib—liver cancer	0.0406	0.0887	CbGbCtD
Ropivacaine—CYP2D6—Doxorubicin—liver cancer	0.0388	0.0846	CbGbCtD
Ropivacaine—CYP3A4—Doxorubicin—liver cancer	0.0246	0.0538	CbGbCtD
Ropivacaine—Albuminuria—Epirubicin—liver cancer	0.00173	0.00464	CcSEcCtD
Ropivacaine—Urethral disorder—Sorafenib—liver cancer	0.00172	0.00461	CcSEcCtD
Ropivacaine—Paralysis—Doxorubicin—liver cancer	0.00172	0.00461	CcSEcCtD
Ropivacaine—Ileus—Doxorubicin—liver cancer	0.00169	0.00453	CcSEcCtD
Ropivacaine—Pleural effusion—Epirubicin—liver cancer	0.00169	0.00452	CcSEcCtD
Ropivacaine—Tinnitus—Sorafenib—liver cancer	0.00164	0.00439	CcSEcCtD
Ropivacaine—Cardiac disorder—Sorafenib—liver cancer	0.00163	0.00437	CcSEcCtD
Ropivacaine—Ventricular arrhythmia—Doxorubicin—liver cancer	0.00162	0.00433	CcSEcCtD
Ropivacaine—Albuminuria—Doxorubicin—liver cancer	0.0016	0.00429	CcSEcCtD
Ropivacaine—Rigors—Epirubicin—liver cancer	0.00158	0.00424	CcSEcCtD
Ropivacaine—Injection site pain—Epirubicin—liver cancer	0.00158	0.00424	CcSEcCtD
Ropivacaine—Arrhythmia—Sorafenib—liver cancer	0.00157	0.0042	CcSEcCtD
Ropivacaine—Pleural effusion—Doxorubicin—liver cancer	0.00156	0.00418	CcSEcCtD
Ropivacaine—Mental disorder—Sorafenib—liver cancer	0.00154	0.00412	CcSEcCtD
Ropivacaine—Erythema—Sorafenib—liver cancer	0.00153	0.0041	CcSEcCtD
Ropivacaine—Muscle spasms—Sorafenib—liver cancer	0.00147	0.00394	CcSEcCtD
Ropivacaine—Rigors—Doxorubicin—liver cancer	0.00146	0.00392	CcSEcCtD
Ropivacaine—Injection site pain—Doxorubicin—liver cancer	0.00146	0.00392	CcSEcCtD
Ropivacaine—Anaemia—Sorafenib—liver cancer	0.00141	0.00379	CcSEcCtD
Ropivacaine—Hypocalcaemia—Epirubicin—liver cancer	0.00141	0.00378	CcSEcCtD
Ropivacaine—Oliguria—Epirubicin—liver cancer	0.0014	0.00376	CcSEcCtD
Ropivacaine—Angioedema—Sorafenib—liver cancer	0.0014	0.00374	CcSEcCtD
Ropivacaine—Dyskinesia—Epirubicin—liver cancer	0.00137	0.00368	CcSEcCtD
Ropivacaine—Syncope—Sorafenib—liver cancer	0.00137	0.00367	CcSEcCtD
Ropivacaine—Dysarthria—Epirubicin—liver cancer	0.00137	0.00366	CcSEcCtD
Ropivacaine—Loss of consciousness—Sorafenib—liver cancer	0.00134	0.0036	CcSEcCtD
Ropivacaine—Cough—Sorafenib—liver cancer	0.00133	0.00357	CcSEcCtD
Ropivacaine—Atrioventricular block—Epirubicin—liver cancer	0.00133	0.00357	CcSEcCtD
Ropivacaine—Hypertension—Sorafenib—liver cancer	0.00132	0.00354	CcSEcCtD
Ropivacaine—Hypocalcaemia—Doxorubicin—liver cancer	0.00131	0.0035	CcSEcCtD
Ropivacaine—Myalgia—Sorafenib—liver cancer	0.0013	0.00349	CcSEcCtD
Ropivacaine—Arthralgia—Sorafenib—liver cancer	0.0013	0.00349	CcSEcCtD
Ropivacaine—Oliguria—Doxorubicin—liver cancer	0.0013	0.00348	CcSEcCtD
Ropivacaine—Ventricular tachycardia—Epirubicin—liver cancer	0.00129	0.00346	CcSEcCtD
Ropivacaine—Pulmonary embolism—Epirubicin—liver cancer	0.00129	0.00346	CcSEcCtD
Ropivacaine—Phosphatase alkaline increased—Epirubicin—liver cancer	0.00129	0.00346	CcSEcCtD
Ropivacaine—Injection site reaction—Epirubicin—liver cancer	0.00128	0.00344	CcSEcCtD
Ropivacaine—Dyskinesia—Doxorubicin—liver cancer	0.00127	0.00341	CcSEcCtD
Ropivacaine—Hyperkalaemia—Epirubicin—liver cancer	0.00127	0.0034	CcSEcCtD
Ropivacaine—Dysarthria—Doxorubicin—liver cancer	0.00126	0.00339	CcSEcCtD
Ropivacaine—Anaphylactic shock—Sorafenib—liver cancer	0.00125	0.00334	CcSEcCtD
Ropivacaine—Infection—Sorafenib—liver cancer	0.00124	0.00332	CcSEcCtD
Ropivacaine—Atrioventricular block—Doxorubicin—liver cancer	0.00123	0.0033	CcSEcCtD
Ropivacaine—Shock—Sorafenib—liver cancer	0.00123	0.00329	CcSEcCtD
Ropivacaine—Thrombocytopenia—Sorafenib—liver cancer	0.00122	0.00327	CcSEcCtD
Ropivacaine—Neuropathy—Epirubicin—liver cancer	0.00121	0.00325	CcSEcCtD
Ropivacaine—Skin disorder—Sorafenib—liver cancer	0.00121	0.00325	CcSEcCtD
Ropivacaine—Pulmonary embolism—Doxorubicin—liver cancer	0.0012	0.0032	CcSEcCtD
Ropivacaine—Ventricular tachycardia—Doxorubicin—liver cancer	0.0012	0.0032	CcSEcCtD
Ropivacaine—Phosphatase alkaline increased—Doxorubicin—liver cancer	0.0012	0.0032	CcSEcCtD
Ropivacaine—Injection site reaction—Doxorubicin—liver cancer	0.00119	0.00319	CcSEcCtD
Ropivacaine—Coma—Epirubicin—liver cancer	0.00118	0.00316	CcSEcCtD
Ropivacaine—Hyperkalaemia—Doxorubicin—liver cancer	0.00117	0.00315	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00114	0.00305	CcSEcCtD
Ropivacaine—Neuropathy—Doxorubicin—liver cancer	0.00112	0.00301	CcSEcCtD
Ropivacaine—Dyspnoea—Sorafenib—liver cancer	0.00111	0.00298	CcSEcCtD
Ropivacaine—Dyspepsia—Sorafenib—liver cancer	0.0011	0.00294	CcSEcCtD
Ropivacaine—Coma—Doxorubicin—liver cancer	0.00109	0.00293	CcSEcCtD
Ropivacaine—Phlebitis—Epirubicin—liver cancer	0.00109	0.00292	CcSEcCtD
Ropivacaine—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.00108	0.00289	CcSEcCtD
Ropivacaine—Hepatic function abnormal—Epirubicin—liver cancer	0.00107	0.00288	CcSEcCtD
Ropivacaine—Pain—Sorafenib—liver cancer	0.00107	0.00286	CcSEcCtD
Ropivacaine—Constipation—Sorafenib—liver cancer	0.00107	0.00286	CcSEcCtD
Ropivacaine—Vascular purpura—Epirubicin—liver cancer	0.00105	0.00281	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Sorafenib—liver cancer	0.00102	0.00273	CcSEcCtD
Ropivacaine—Phlebitis—Doxorubicin—liver cancer	0.00101	0.0027	CcSEcCtD
Ropivacaine—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.000998	0.00267	CcSEcCtD
Ropivacaine—Hepatic function abnormal—Doxorubicin—liver cancer	0.000993	0.00266	CcSEcCtD
Ropivacaine—Urticaria—Sorafenib—liver cancer	0.000991	0.00266	CcSEcCtD
Ropivacaine—Body temperature increased—Sorafenib—liver cancer	0.000986	0.00264	CcSEcCtD
Ropivacaine—Abdominal pain—Sorafenib—liver cancer	0.000986	0.00264	CcSEcCtD
Ropivacaine—Purpura—Epirubicin—liver cancer	0.000973	0.00261	CcSEcCtD
Ropivacaine—Vascular purpura—Doxorubicin—liver cancer	0.00097	0.0026	CcSEcCtD
Ropivacaine—Anaphylactoid reaction—Epirubicin—liver cancer	0.000969	0.0026	CcSEcCtD
Ropivacaine—Hypoglycaemia—Epirubicin—liver cancer	0.000961	0.00258	CcSEcCtD
Ropivacaine—Osteoarthritis—Epirubicin—liver cancer	0.000938	0.00251	CcSEcCtD
Ropivacaine—Affect lability—Epirubicin—liver cancer	0.000923	0.00247	CcSEcCtD
Ropivacaine—Hypersensitivity—Sorafenib—liver cancer	0.000919	0.00246	CcSEcCtD
Ropivacaine—Purpura—Doxorubicin—liver cancer	0.0009	0.00241	CcSEcCtD
Ropivacaine—Anaphylactoid reaction—Doxorubicin—liver cancer	0.000897	0.0024	CcSEcCtD
Ropivacaine—Asthenia—Sorafenib—liver cancer	0.000895	0.0024	CcSEcCtD
Ropivacaine—Cardiac arrest—Epirubicin—liver cancer	0.000892	0.00239	CcSEcCtD
Ropivacaine—Hypoglycaemia—Doxorubicin—liver cancer	0.000889	0.00238	CcSEcCtD
Ropivacaine—Mood swings—Epirubicin—liver cancer	0.000888	0.00238	CcSEcCtD
Ropivacaine—Pruritus—Sorafenib—liver cancer	0.000882	0.00237	CcSEcCtD
Ropivacaine—Osteoarthritis—Doxorubicin—liver cancer	0.000868	0.00233	CcSEcCtD
Ropivacaine—Orthostatic hypotension—Epirubicin—liver cancer	0.000857	0.0023	CcSEcCtD
Ropivacaine—Affect lability—Doxorubicin—liver cancer	0.000854	0.00229	CcSEcCtD
Ropivacaine—Hypokalaemia—Epirubicin—liver cancer	0.000853	0.00229	CcSEcCtD
Ropivacaine—Diarrhoea—Sorafenib—liver cancer	0.000853	0.00229	CcSEcCtD
Ropivacaine—Breast disorder—Epirubicin—liver cancer	0.000847	0.00227	CcSEcCtD
Ropivacaine—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000844	0.00226	CcSEcCtD
Ropivacaine—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000827	0.00222	CcSEcCtD
Ropivacaine—Cardiac arrest—Doxorubicin—liver cancer	0.000825	0.00221	CcSEcCtD
Ropivacaine—Dizziness—Sorafenib—liver cancer	0.000825	0.00221	CcSEcCtD
Ropivacaine—Mood swings—Doxorubicin—liver cancer	0.000822	0.0022	CcSEcCtD
Ropivacaine—Abdominal distension—Epirubicin—liver cancer	0.000816	0.00219	CcSEcCtD
Ropivacaine—Vomiting—Sorafenib—liver cancer	0.000793	0.00213	CcSEcCtD
Ropivacaine—Orthostatic hypotension—Doxorubicin—liver cancer	0.000793	0.00212	CcSEcCtD
Ropivacaine—Hypokalaemia—Doxorubicin—liver cancer	0.00079	0.00212	CcSEcCtD
Ropivacaine—Rash—Sorafenib—liver cancer	0.000786	0.00211	CcSEcCtD
Ropivacaine—Dermatitis—Sorafenib—liver cancer	0.000786	0.00211	CcSEcCtD
Ropivacaine—Breast disorder—Doxorubicin—liver cancer	0.000784	0.0021	CcSEcCtD
Ropivacaine—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000781	0.00209	CcSEcCtD
Ropivacaine—Headache—Sorafenib—liver cancer	0.000781	0.00209	CcSEcCtD
Ropivacaine—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000765	0.00205	CcSEcCtD
Ropivacaine—Dysuria—Epirubicin—liver cancer	0.000758	0.00203	CcSEcCtD
Ropivacaine—Abdominal distension—Doxorubicin—liver cancer	0.000755	0.00202	CcSEcCtD
Ropivacaine—Nausea—Sorafenib—liver cancer	0.000741	0.00199	CcSEcCtD
Ropivacaine—Hyperglycaemia—Epirubicin—liver cancer	0.000731	0.00196	CcSEcCtD
Ropivacaine—Drowsiness—Epirubicin—liver cancer	0.000723	0.00194	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Epirubicin—liver cancer	0.000708	0.0019	CcSEcCtD
Ropivacaine—Jaundice—Epirubicin—liver cancer	0.000704	0.00189	CcSEcCtD
Ropivacaine—Urinary tract infection—Epirubicin—liver cancer	0.000702	0.00188	CcSEcCtD
Ropivacaine—Dysuria—Doxorubicin—liver cancer	0.000701	0.00188	CcSEcCtD
Ropivacaine—Haematuria—Epirubicin—liver cancer	0.000689	0.00185	CcSEcCtD
Ropivacaine—Hyperglycaemia—Doxorubicin—liver cancer	0.000677	0.00181	CcSEcCtD
Ropivacaine—Drowsiness—Doxorubicin—liver cancer	0.000669	0.00179	CcSEcCtD
Ropivacaine—Bradycardia—Epirubicin—liver cancer	0.00066	0.00177	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Doxorubicin—liver cancer	0.000655	0.00176	CcSEcCtD
Ropivacaine—Jaundice—Doxorubicin—liver cancer	0.000652	0.00175	CcSEcCtD
Ropivacaine—Rhinitis—Epirubicin—liver cancer	0.00065	0.00174	CcSEcCtD
Ropivacaine—Urinary tract infection—Doxorubicin—liver cancer	0.00065	0.00174	CcSEcCtD
Ropivacaine—Hypoaesthesia—Epirubicin—liver cancer	0.000646	0.00173	CcSEcCtD
Ropivacaine—Urinary tract disorder—Epirubicin—liver cancer	0.000641	0.00172	CcSEcCtD
Ropivacaine—Oedema peripheral—Epirubicin—liver cancer	0.000639	0.00171	CcSEcCtD
Ropivacaine—Haematuria—Doxorubicin—liver cancer	0.000638	0.00171	CcSEcCtD
Ropivacaine—Urethral disorder—Epirubicin—liver cancer	0.000636	0.0017	CcSEcCtD
Ropivacaine—Bradycardia—Doxorubicin—liver cancer	0.000611	0.00164	CcSEcCtD
Ropivacaine—Tinnitus—Epirubicin—liver cancer	0.000605	0.00162	CcSEcCtD
Ropivacaine—Cardiac disorder—Epirubicin—liver cancer	0.000602	0.00161	CcSEcCtD
Ropivacaine—Rhinitis—Doxorubicin—liver cancer	0.000602	0.00161	CcSEcCtD
Ropivacaine—Hypoaesthesia—Doxorubicin—liver cancer	0.000597	0.0016	CcSEcCtD
Ropivacaine—Urinary tract disorder—Doxorubicin—liver cancer	0.000593	0.00159	CcSEcCtD
Ropivacaine—Oedema peripheral—Doxorubicin—liver cancer	0.000591	0.00159	CcSEcCtD
Ropivacaine—Urethral disorder—Doxorubicin—liver cancer	0.000588	0.00158	CcSEcCtD
Ropivacaine—Chills—Epirubicin—liver cancer	0.000582	0.00156	CcSEcCtD
Ropivacaine—Arrhythmia—Epirubicin—liver cancer	0.00058	0.00155	CcSEcCtD
Ropivacaine—Mental disorder—Epirubicin—liver cancer	0.000568	0.00152	CcSEcCtD
Ropivacaine—Erythema—Epirubicin—liver cancer	0.000565	0.00151	CcSEcCtD
Ropivacaine—Tinnitus—Doxorubicin—liver cancer	0.00056	0.0015	CcSEcCtD
Ropivacaine—Cardiac disorder—Doxorubicin—liver cancer	0.000557	0.00149	CcSEcCtD
Ropivacaine—Tension—Epirubicin—liver cancer	0.000554	0.00149	CcSEcCtD
Ropivacaine—Nervousness—Epirubicin—liver cancer	0.000549	0.00147	CcSEcCtD
Ropivacaine—Back pain—Epirubicin—liver cancer	0.000546	0.00146	CcSEcCtD
Ropivacaine—Muscle spasms—Epirubicin—liver cancer	0.000543	0.00146	CcSEcCtD
Ropivacaine—Chills—Doxorubicin—liver cancer	0.000539	0.00144	CcSEcCtD
Ropivacaine—Arrhythmia—Doxorubicin—liver cancer	0.000536	0.00144	CcSEcCtD
Ropivacaine—Vision blurred—Epirubicin—liver cancer	0.000532	0.00143	CcSEcCtD
Ropivacaine—Mental disorder—Doxorubicin—liver cancer	0.000526	0.00141	CcSEcCtD
Ropivacaine—Ill-defined disorder—Epirubicin—liver cancer	0.000524	0.0014	CcSEcCtD
Ropivacaine—Erythema—Doxorubicin—liver cancer	0.000523	0.0014	CcSEcCtD
Ropivacaine—Anaemia—Epirubicin—liver cancer	0.000522	0.0014	CcSEcCtD
Ropivacaine—Agitation—Epirubicin—liver cancer	0.000519	0.00139	CcSEcCtD
Ropivacaine—Tension—Doxorubicin—liver cancer	0.000513	0.00137	CcSEcCtD
Ropivacaine—Malaise—Epirubicin—liver cancer	0.000509	0.00137	CcSEcCtD
Ropivacaine—Nervousness—Doxorubicin—liver cancer	0.000508	0.00136	CcSEcCtD
Ropivacaine—Vertigo—Epirubicin—liver cancer	0.000507	0.00136	CcSEcCtD
Ropivacaine—Syncope—Epirubicin—liver cancer	0.000506	0.00136	CcSEcCtD
Ropivacaine—Back pain—Doxorubicin—liver cancer	0.000505	0.00135	CcSEcCtD
Ropivacaine—Muscle spasms—Doxorubicin—liver cancer	0.000502	0.00135	CcSEcCtD
Ropivacaine—Loss of consciousness—Epirubicin—liver cancer	0.000496	0.00133	CcSEcCtD
Ropivacaine—Cough—Epirubicin—liver cancer	0.000493	0.00132	CcSEcCtD
Ropivacaine—Vision blurred—Doxorubicin—liver cancer	0.000492	0.00132	CcSEcCtD
Ropivacaine—Convulsion—Epirubicin—liver cancer	0.000489	0.00131	CcSEcCtD
Ropivacaine—Hypertension—Epirubicin—liver cancer	0.000488	0.00131	CcSEcCtD
Ropivacaine—Ill-defined disorder—Doxorubicin—liver cancer	0.000485	0.0013	CcSEcCtD
Ropivacaine—Anaemia—Doxorubicin—liver cancer	0.000483	0.00129	CcSEcCtD
Ropivacaine—Arthralgia—Epirubicin—liver cancer	0.000481	0.00129	CcSEcCtD
Ropivacaine—Chest pain—Epirubicin—liver cancer	0.000481	0.00129	CcSEcCtD
Ropivacaine—Myalgia—Epirubicin—liver cancer	0.000481	0.00129	CcSEcCtD
Ropivacaine—Agitation—Doxorubicin—liver cancer	0.00048	0.00129	CcSEcCtD
Ropivacaine—Anxiety—Epirubicin—liver cancer	0.000479	0.00128	CcSEcCtD
Ropivacaine—Discomfort—Epirubicin—liver cancer	0.000475	0.00127	CcSEcCtD
Ropivacaine—Malaise—Doxorubicin—liver cancer	0.000471	0.00126	CcSEcCtD
Ropivacaine—Vertigo—Doxorubicin—liver cancer	0.000469	0.00126	CcSEcCtD
Ropivacaine—Syncope—Doxorubicin—liver cancer	0.000469	0.00126	CcSEcCtD
Ropivacaine—Confusional state—Epirubicin—liver cancer	0.000465	0.00125	CcSEcCtD
Ropivacaine—Anaphylactic shock—Epirubicin—liver cancer	0.000461	0.00124	CcSEcCtD
Ropivacaine—Loss of consciousness—Doxorubicin—liver cancer	0.000459	0.00123	CcSEcCtD
Ropivacaine—Infection—Epirubicin—liver cancer	0.000458	0.00123	CcSEcCtD
Ropivacaine—Cough—Doxorubicin—liver cancer	0.000456	0.00122	CcSEcCtD
Ropivacaine—Shock—Epirubicin—liver cancer	0.000453	0.00122	CcSEcCtD
Ropivacaine—Convulsion—Doxorubicin—liver cancer	0.000453	0.00121	CcSEcCtD
Ropivacaine—Thrombocytopenia—Epirubicin—liver cancer	0.000451	0.00121	CcSEcCtD
Ropivacaine—Hypertension—Doxorubicin—liver cancer	0.000451	0.00121	CcSEcCtD
Ropivacaine—Tachycardia—Epirubicin—liver cancer	0.00045	0.00121	CcSEcCtD
Ropivacaine—Skin disorder—Epirubicin—liver cancer	0.000448	0.0012	CcSEcCtD
Ropivacaine—Hyperhidrosis—Epirubicin—liver cancer	0.000446	0.00119	CcSEcCtD
Ropivacaine—Arthralgia—Doxorubicin—liver cancer	0.000445	0.00119	CcSEcCtD
Ropivacaine—Chest pain—Doxorubicin—liver cancer	0.000445	0.00119	CcSEcCtD
Ropivacaine—Myalgia—Doxorubicin—liver cancer	0.000445	0.00119	CcSEcCtD
Ropivacaine—Anxiety—Doxorubicin—liver cancer	0.000443	0.00119	CcSEcCtD
Ropivacaine—Discomfort—Doxorubicin—liver cancer	0.00044	0.00118	CcSEcCtD
Ropivacaine—Hypotension—Epirubicin—liver cancer	0.000431	0.00115	CcSEcCtD
Ropivacaine—Confusional state—Doxorubicin—liver cancer	0.00043	0.00115	CcSEcCtD
Ropivacaine—Anaphylactic shock—Doxorubicin—liver cancer	0.000426	0.00114	CcSEcCtD
Ropivacaine—Infection—Doxorubicin—liver cancer	0.000424	0.00114	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00042	0.00113	CcSEcCtD
Ropivacaine—Shock—Doxorubicin—liver cancer	0.00042	0.00112	CcSEcCtD
Ropivacaine—Thrombocytopenia—Doxorubicin—liver cancer	0.000418	0.00112	CcSEcCtD
Ropivacaine—Insomnia—Epirubicin—liver cancer	0.000417	0.00112	CcSEcCtD
Ropivacaine—Tachycardia—Doxorubicin—liver cancer	0.000416	0.00112	CcSEcCtD
Ropivacaine—Skin disorder—Doxorubicin—liver cancer	0.000414	0.00111	CcSEcCtD
Ropivacaine—Paraesthesia—Epirubicin—liver cancer	0.000414	0.00111	CcSEcCtD
Ropivacaine—Hyperhidrosis—Doxorubicin—liver cancer	0.000412	0.00111	CcSEcCtD
Ropivacaine—Dyspnoea—Epirubicin—liver cancer	0.000411	0.0011	CcSEcCtD
Ropivacaine—Somnolence—Epirubicin—liver cancer	0.00041	0.0011	CcSEcCtD
Ropivacaine—Dyspepsia—Epirubicin—liver cancer	0.000406	0.00109	CcSEcCtD
Ropivacaine—Hypotension—Doxorubicin—liver cancer	0.000399	0.00107	CcSEcCtD
Ropivacaine—Constipation—Epirubicin—liver cancer	0.000394	0.00106	CcSEcCtD
Ropivacaine—Pain—Epirubicin—liver cancer	0.000394	0.00106	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000389	0.00104	CcSEcCtD
Ropivacaine—Insomnia—Doxorubicin—liver cancer	0.000386	0.00103	CcSEcCtD
Ropivacaine—Paraesthesia—Doxorubicin—liver cancer	0.000383	0.00103	CcSEcCtD
Ropivacaine—Dyspnoea—Doxorubicin—liver cancer	0.00038	0.00102	CcSEcCtD
Ropivacaine—Feeling abnormal—Epirubicin—liver cancer	0.00038	0.00102	CcSEcCtD
Ropivacaine—Somnolence—Doxorubicin—liver cancer	0.000379	0.00102	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Epirubicin—liver cancer	0.000377	0.00101	CcSEcCtD
Ropivacaine—Dyspepsia—Doxorubicin—liver cancer	0.000375	0.00101	CcSEcCtD
Ropivacaine—Urticaria—Epirubicin—liver cancer	0.000366	0.000982	CcSEcCtD
Ropivacaine—Pain—Doxorubicin—liver cancer	0.000365	0.000978	CcSEcCtD
Ropivacaine—Constipation—Doxorubicin—liver cancer	0.000365	0.000978	CcSEcCtD
Ropivacaine—Abdominal pain—Epirubicin—liver cancer	0.000364	0.000977	CcSEcCtD
Ropivacaine—Body temperature increased—Epirubicin—liver cancer	0.000364	0.000977	CcSEcCtD
Ropivacaine—Feeling abnormal—Doxorubicin—liver cancer	0.000351	0.000942	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000349	0.000935	CcSEcCtD
Ropivacaine—Hypersensitivity—Epirubicin—liver cancer	0.00034	0.00091	CcSEcCtD
Ropivacaine—Urticaria—Doxorubicin—liver cancer	0.000339	0.000908	CcSEcCtD
Ropivacaine—Abdominal pain—Doxorubicin—liver cancer	0.000337	0.000904	CcSEcCtD
Ropivacaine—Body temperature increased—Doxorubicin—liver cancer	0.000337	0.000904	CcSEcCtD
Ropivacaine—Asthenia—Epirubicin—liver cancer	0.000331	0.000886	CcSEcCtD
Ropivacaine—Pruritus—Epirubicin—liver cancer	0.000326	0.000874	CcSEcCtD
Ropivacaine—Diarrhoea—Epirubicin—liver cancer	0.000315	0.000845	CcSEcCtD
Ropivacaine—Hypersensitivity—Doxorubicin—liver cancer	0.000314	0.000842	CcSEcCtD
Ropivacaine—Asthenia—Doxorubicin—liver cancer	0.000306	0.00082	CcSEcCtD
Ropivacaine—Dizziness—Epirubicin—liver cancer	0.000305	0.000817	CcSEcCtD
Ropivacaine—Pruritus—Doxorubicin—liver cancer	0.000302	0.000809	CcSEcCtD
Ropivacaine—Vomiting—Epirubicin—liver cancer	0.000293	0.000786	CcSEcCtD
Ropivacaine—Diarrhoea—Doxorubicin—liver cancer	0.000292	0.000782	CcSEcCtD
Ropivacaine—Rash—Epirubicin—liver cancer	0.000291	0.000779	CcSEcCtD
Ropivacaine—Dermatitis—Epirubicin—liver cancer	0.00029	0.000778	CcSEcCtD
Ropivacaine—Headache—Epirubicin—liver cancer	0.000289	0.000774	CcSEcCtD
Ropivacaine—Dizziness—Doxorubicin—liver cancer	0.000282	0.000756	CcSEcCtD
Ropivacaine—Nausea—Epirubicin—liver cancer	0.000274	0.000734	CcSEcCtD
Ropivacaine—Vomiting—Doxorubicin—liver cancer	0.000271	0.000727	CcSEcCtD
Ropivacaine—Rash—Doxorubicin—liver cancer	0.000269	0.000721	CcSEcCtD
Ropivacaine—Dermatitis—Doxorubicin—liver cancer	0.000269	0.00072	CcSEcCtD
Ropivacaine—Headache—Doxorubicin—liver cancer	0.000267	0.000716	CcSEcCtD
Ropivacaine—Nausea—Doxorubicin—liver cancer	0.000253	0.000679	CcSEcCtD
Ropivacaine—SCN9A—Developmental Biology—VEGFA—liver cancer	0.000108	0.000641	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—STAT3—liver cancer	0.000107	0.000635	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—MMP9—liver cancer	0.000107	0.000632	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—MMP9—liver cancer	0.000107	0.000632	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—EPT1—liver cancer	0.000106	0.000625	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—MMP9—liver cancer	0.000105	0.000623	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—IL6—liver cancer	0.000105	0.000621	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—HRAS—liver cancer	0.000105	0.000621	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—CYP1A1—liver cancer	0.000104	0.000617	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—VEGFA—liver cancer	0.000104	0.000613	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—CYP1A1—liver cancer	0.000103	0.000609	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—STAT3—liver cancer	0.000103	0.000607	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—liver cancer	0.000102	0.000603	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—liver cancer	0.000102	0.000603	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—GSTP1—liver cancer	0.000101	0.0006	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—liver cancer	0.000101	0.000598	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—HRAS—liver cancer	0.000101	0.000596	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—HRAS—liver cancer	0.000101	0.000596	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—IL6—liver cancer	0.0001	0.000594	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—TAT—liver cancer	0.0001	0.000592	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—GSTP1—liver cancer	0.0001	0.000592	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—MMP2—liver cancer	0.0001	0.000592	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—VEGFA—liver cancer	9.95e-05	0.000589	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—VEGFA—liver cancer	9.95e-05	0.000589	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—TGFB1—liver cancer	9.94e-05	0.000588	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—STAT3—liver cancer	9.85e-05	0.000583	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—STAT3—liver cancer	9.85e-05	0.000583	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—HRAS—liver cancer	9.72e-05	0.000575	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—HRAS—liver cancer	9.72e-05	0.000575	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—HRAS—liver cancer	9.68e-05	0.000573	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—IL6—liver cancer	9.65e-05	0.000571	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—IL6—liver cancer	9.65e-05	0.000571	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—VEGFA—liver cancer	9.6e-05	0.000568	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—VEGFA—liver cancer	9.6e-05	0.000568	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—TGFB1—liver cancer	9.51e-05	0.000563	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—STAT3—liver cancer	9.5e-05	0.000562	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—STAT3—liver cancer	9.5e-05	0.000562	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—CYP2E1—liver cancer	9.49e-05	0.000562	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—VEGFA—liver cancer	9.45e-05	0.000559	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	9.36e-05	0.000554	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—GSTM1—liver cancer	9.32e-05	0.000552	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—IL6—liver cancer	9.3e-05	0.00055	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—IL6—liver cancer	9.3e-05	0.00055	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—TNF—liver cancer	9.28e-05	0.000549	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—IL6—liver cancer	9.26e-05	0.000548	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—KRAS—liver cancer	9.21e-05	0.000545	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—GSTM1—liver cancer	9.19e-05	0.000544	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—TGFB1—liver cancer	9.13e-05	0.000541	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—TGFB1—liver cancer	9.13e-05	0.000541	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	8.99e-05	0.000532	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—TNF—liver cancer	8.88e-05	0.000525	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—RAF1—liver cancer	8.85e-05	0.000524	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—CYP1A1—liver cancer	8.84e-05	0.000523	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—TGFB1—liver cancer	8.81e-05	0.000521	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—TGFB1—liver cancer	8.81e-05	0.000521	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—KRAS—liver cancer	8.81e-05	0.000521	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—GGT1—liver cancer	8.72e-05	0.000516	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—CYP1A1—liver cancer	8.72e-05	0.000516	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	8.67e-05	0.000513	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—liver cancer	8.59e-05	0.000508	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—AKT1—liver cancer	8.54e-05	0.000506	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—TNF—liver cancer	8.53e-05	0.000505	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—TNF—liver cancer	8.53e-05	0.000505	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—KRAS—liver cancer	8.46e-05	0.000501	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—KRAS—liver cancer	8.46e-05	0.000501	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—TNF—liver cancer	8.22e-05	0.000487	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—TNF—liver cancer	8.22e-05	0.000487	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—KRAS—liver cancer	8.16e-05	0.000483	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—KRAS—liver cancer	8.16e-05	0.000483	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—KRAS—liver cancer	8.04e-05	0.000476	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—GSTP1—liver cancer	7.83e-05	0.000463	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—HRAS—liver cancer	7.83e-05	0.000463	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—UGDH—liver cancer	7.8e-05	0.000462	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	7.72e-05	0.000457	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—CTNNB1—liver cancer	7.66e-05	0.000454	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—MMP9—liver cancer	7.51e-05	0.000445	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—IL6—liver cancer	7.49e-05	0.000443	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—HRAS—liver cancer	7.49e-05	0.000443	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—EPT1—liver cancer	7.34e-05	0.000434	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—GSTM1—liver cancer	7.19e-05	0.000426	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—HRAS—liver cancer	7.19e-05	0.000426	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—HRAS—liver cancer	7.19e-05	0.000426	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—IL6—liver cancer	7.16e-05	0.000424	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	7.1e-05	0.00042	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—TAT—liver cancer	6.95e-05	0.000411	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—HRAS—liver cancer	6.93e-05	0.00041	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—HRAS—liver cancer	6.93e-05	0.00041	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—AKT1—liver cancer	6.91e-05	0.000409	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—IL6—liver cancer	6.88e-05	0.000407	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—IL6—liver cancer	6.88e-05	0.000407	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—HRAS—liver cancer	6.83e-05	0.000404	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—CYP1A1—liver cancer	6.82e-05	0.000404	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CPT1B—liver cancer	6.8e-05	0.000402	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GLUL—liver cancer	6.8e-05	0.000402	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—VEGFA—liver cancer	6.75e-05	0.000399	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	6.73e-05	0.000398	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—STAT3—liver cancer	6.68e-05	0.000395	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—IL6—liver cancer	6.64e-05	0.000393	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—IL6—liver cancer	6.64e-05	0.000393	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	6.63e-05	0.000392	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—AKT1—liver cancer	6.61e-05	0.000391	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—UGDH—liver cancer	6.61e-05	0.000391	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—NR1H4—liver cancer	6.56e-05	0.000388	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—IL6—liver cancer	6.54e-05	0.000387	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GSTA3—liver cancer	6.45e-05	0.000382	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—AKT1—liver cancer	6.35e-05	0.000376	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—AKT1—liver cancer	6.35e-05	0.000376	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—EPT1—liver cancer	6.21e-05	0.000368	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—TGFB1—liver cancer	6.19e-05	0.000366	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—AKT1—liver cancer	6.12e-05	0.000362	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—AKT1—liver cancer	6.12e-05	0.000362	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GSTA4—liver cancer	5.9e-05	0.000349	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—TAT—liver cancer	5.89e-05	0.000349	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	5.79e-05	0.000343	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—TNF—liver cancer	5.78e-05	0.000342	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GSTA2—liver cancer	5.75e-05	0.00034	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—KRAS—liver cancer	5.74e-05	0.000339	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GSTA1—liver cancer	5.54e-05	0.000328	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—NAT2—liver cancer	5.48e-05	0.000324	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ALDOB—liver cancer	5.26e-05	0.000311	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—UGDH—liver cancer	5.1e-05	0.000302	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CRABP1—liver cancer	5.01e-05	0.000297	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—HRAS—liver cancer	4.88e-05	0.000289	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—EPT1—liver cancer	4.8e-05	0.000284	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CPT1B—liver cancer	4.73e-05	0.00028	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GLUL—liver cancer	4.73e-05	0.00028	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—IL6—liver cancer	4.67e-05	0.000276	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—NR1H4—liver cancer	4.56e-05	0.00027	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—TAT—liver cancer	4.55e-05	0.000269	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GSTA3—liver cancer	4.48e-05	0.000265	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—HPGDS—liver cancer	4.38e-05	0.000259	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	4.34e-05	0.000257	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—AKT1—liver cancer	4.3e-05	0.000255	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GSTA4—liver cancer	4.1e-05	0.000243	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CPT1B—liver cancer	4e-05	0.000237	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GLUL—liver cancer	4e-05	0.000237	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GSTA2—liver cancer	3.99e-05	0.000236	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PSMA4—liver cancer	3.91e-05	0.000231	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PSMD10—liver cancer	3.91e-05	0.000231	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—NR1H4—liver cancer	3.86e-05	0.000228	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GSTA1—liver cancer	3.85e-05	0.000228	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—NAT2—liver cancer	3.81e-05	0.000225	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GOT2—liver cancer	3.8e-05	0.000225	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GSTA3—liver cancer	3.8e-05	0.000225	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ALDOB—liver cancer	3.65e-05	0.000216	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYP2E1—liver cancer	3.57e-05	0.000211	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CRABP1—liver cancer	3.48e-05	0.000206	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GSTA4—liver cancer	3.47e-05	0.000205	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.39e-05	0.000201	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GSTA2—liver cancer	3.38e-05	0.0002	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYCS—liver cancer	3.34e-05	0.000198	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GOT1—liver cancer	3.28e-05	0.000194	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GGT1—liver cancer	3.28e-05	0.000194	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GSTA1—liver cancer	3.26e-05	0.000193	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—NAT2—liver cancer	3.23e-05	0.000191	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.1e-05	0.000184	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ALDOB—liver cancer	3.09e-05	0.000183	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CPT1B—liver cancer	3.09e-05	0.000183	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GLUL—liver cancer	3.09e-05	0.000183	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—HPGDS—liver cancer	3.05e-05	0.00018	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—NR1H4—liver cancer	2.98e-05	0.000176	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CRABP1—liver cancer	2.95e-05	0.000175	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GSTP1—liver cancer	2.95e-05	0.000174	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GSTA3—liver cancer	2.93e-05	0.000173	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—HMOX1—liver cancer	2.91e-05	0.000172	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PSMD10—liver cancer	2.71e-05	0.000161	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PSMA4—liver cancer	2.71e-05	0.000161	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GSTM1—liver cancer	2.71e-05	0.00016	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GSTA4—liver cancer	2.68e-05	0.000159	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.66e-05	0.000157	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GOT2—liver cancer	2.64e-05	0.000156	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GSTA2—liver cancer	2.61e-05	0.000155	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—HPGDS—liver cancer	2.58e-05	0.000153	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYP1A1—liver cancer	2.57e-05	0.000152	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.57e-05	0.000152	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GSTA1—liver cancer	2.52e-05	0.000149	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—NAT2—liver cancer	2.49e-05	0.000147	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYP2E1—liver cancer	2.48e-05	0.000147	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—MTHFR—liver cancer	2.39e-05	0.000142	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ALDOB—liver cancer	2.39e-05	0.000141	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PPARA—liver cancer	2.35e-05	0.000139	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.34e-05	0.000138	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYCS—liver cancer	2.32e-05	0.000137	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.31e-05	0.000136	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PSMD10—liver cancer	2.3e-05	0.000136	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PSMA4—liver cancer	2.3e-05	0.000136	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GGT1—liver cancer	2.28e-05	0.000135	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GOT1—liver cancer	2.28e-05	0.000135	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CRABP1—liver cancer	2.28e-05	0.000135	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GOT2—liver cancer	2.24e-05	0.000132	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP2E1—liver cancer	2.1e-05	0.000124	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GSTP1—liver cancer	2.05e-05	0.000121	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.04e-05	0.000121	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—HMOX1—liver cancer	2.02e-05	0.00012	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PIK3CG—liver cancer	2.01e-05	0.000119	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—HPGDS—liver cancer	1.99e-05	0.000118	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYCS—liver cancer	1.97e-05	0.000116	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PPARG—liver cancer	1.94e-05	0.000115	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GGT1—liver cancer	1.93e-05	0.000114	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GOT1—liver cancer	1.93e-05	0.000114	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GSTM1—liver cancer	1.88e-05	0.000111	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYP1A1—liver cancer	1.78e-05	0.000106	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PSMA4—liver cancer	1.77e-05	0.000105	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PSMD10—liver cancer	1.77e-05	0.000105	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PIK3CD—liver cancer	1.77e-05	0.000105	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ALB—liver cancer	1.74e-05	0.000103	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GSTP1—liver cancer	1.73e-05	0.000103	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GOT2—liver cancer	1.73e-05	0.000102	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—HMOX1—liver cancer	1.71e-05	0.000101	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—MTHFR—liver cancer	1.66e-05	9.84e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PPARA—liver cancer	1.63e-05	9.66e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP2E1—liver cancer	1.62e-05	9.61e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GSTM1—liver cancer	1.59e-05	9.43e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PIK3CB—liver cancer	1.54e-05	9.12e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYCS—liver cancer	1.52e-05	8.99e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP1A1—liver cancer	1.51e-05	8.94e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GGT1—liver cancer	1.49e-05	8.82e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GOT1—liver cancer	1.49e-05	8.82e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—MTHFR—liver cancer	1.41e-05	8.34e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PIK3CG—liver cancer	1.4e-05	8.27e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PPARA—liver cancer	1.38e-05	8.18e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PPARG—liver cancer	1.35e-05	7.98e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GSTP1—liver cancer	1.34e-05	7.92e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—HMOX1—liver cancer	1.32e-05	7.81e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.24e-05	7.35e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GSTM1—liver cancer	1.23e-05	7.28e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PIK3CD—liver cancer	1.23e-05	7.27e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ALB—liver cancer	1.21e-05	7.18e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PIK3CG—liver cancer	1.18e-05	7e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP1A1—liver cancer	1.17e-05	6.9e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PPARG—liver cancer	1.14e-05	6.76e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—MTHFR—liver cancer	1.09e-05	6.43e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PIK3CB—liver cancer	1.07e-05	6.34e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PPARA—liver cancer	1.07e-05	6.31e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PIK3CD—liver cancer	1.04e-05	6.16e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ALB—liver cancer	1.03e-05	6.08e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PIK3CA—liver cancer	9.39e-06	5.56e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PIK3CG—liver cancer	9.14e-06	5.41e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PIK3CB—liver cancer	9.07e-06	5.37e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PPARG—liver cancer	8.82e-06	5.22e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PIK3CD—liver cancer	8.03e-06	4.75e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ALB—liver cancer	7.93e-06	4.69e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—AKT1—liver cancer	7.67e-06	4.54e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PIK3CB—liver cancer	7e-06	4.14e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PIK3CA—liver cancer	6.53e-06	3.86e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PIK3CA—liver cancer	5.53e-06	3.27e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—AKT1—liver cancer	5.33e-06	3.16e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—AKT1—liver cancer	4.52e-06	2.67e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PIK3CA—liver cancer	4.27e-06	2.53e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—AKT1—liver cancer	3.49e-06	2.06e-05	CbGpPWpGaD
